On-line dose-guidance to account for inter-fractional motion during proton therapy
- PMID: 33458420
- PMCID: PMC7807653
- DOI: 10.1016/j.phro.2018.11.009
On-line dose-guidance to account for inter-fractional motion during proton therapy
Abstract
Background and purpose: Proton therapy (PT) of extra-cranial tumour sites is challenged by density changes caused by inter-fractional organ motion. In this study we investigate on-line dose-guided PT (DGPT) to account inter-fractional target motion, exemplified by internal motion in the pelvis.
Materials and methods: On-line DGPT involved re-calculating dose distributions with the isocenter shifted up to 15 mm from the position corresponding to conventional soft-tissue based image-guided PT (IGPT). The method was applied to patient models with simulated prostate/seminal vesicle target motion of ±3, ±5 and ±10 mm along the three cardinal axes. Treatment plans were created using either two lateral (gantry angles of 90°/270°) or two lateral oblique fields (gantry angles of 35°/325°). Target coverage and normal tissue doses from DGPT were compared to both soft-tissue and bony anatomy based IGPT.
Results: DGPT improved the dose distributions relative to soft-tissue based IGPT for 39 of 90 simulation scenarios using lateral fields and for 50 of 90 scenarios using lateral oblique fields. The greatest benefits of DGPT were seen for large motion, e.g. a median target coverage improvement of 13% was found for 10 mm anterior motion with lateral fields. DGPT also improved the dose distribution in comparison to bony anatomy IGPT in all cases. The best strategy was often to move the fields back towards the original target position prior to the simulated target motion.
Conclusion: DGPT has the potential to better account for large inter-fractional organ motion in the pelvis than IGPT.
© 2018 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.
Figures



Similar articles
-
Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.Acta Oncol. 2013 Apr;52(3):521-7. doi: 10.3109/0284186X.2012.752860. Epub 2013 Feb 14. Acta Oncol. 2013. PMID: 23409771
-
Evaluating the influence of organ motion during photon vs. proton therapy for locally advanced prostate cancer using biological models.Acta Oncol. 2017 Jun;56(6):839-845. doi: 10.1080/0284186X.2017.1317107. Acta Oncol. 2017. PMID: 28464733
-
A Beam-Angle-Selection Method to Improve Inter-Fraction Motion Robustness for Lung Tumor Irradiation With Passive Proton Scattering.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948052. doi: 10.1177/1533033820948052. Technol Cancer Res Treat. 2020. PMID: 32844716 Free PMC article.
-
Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.Med Phys. 2021 Jan;48(1):397-413. doi: 10.1002/mp.14579. Epub 2020 Nov 23. Med Phys. 2021. PMID: 33151543
-
Towards range-guidance in proton therapy to detect organ motion-induced dose degradations.Biomed Phys Eng Express. 2022 Feb 18;8(2). doi: 10.1088/2057-1976/ac5151. Biomed Phys Eng Express. 2022. PMID: 35108695
Cited by
-
Proton therapy planning and image-guidance strategies within a randomized controlled trial for high-risk prostate cancer.Clin Transl Radiat Oncol. 2023 Apr 25;41:100632. doi: 10.1016/j.ctro.2023.100632. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37441541 Free PMC article.
-
Impact of interfractional target motion in locally advanced cervical cancer patients treated with spot scanning proton therapy using an internal target volume strategy.Phys Imaging Radiat Oncol. 2021 Feb 6;17:84-90. doi: 10.1016/j.phro.2021.01.010. eCollection 2021 Jan. Phys Imaging Radiat Oncol. 2021. PMID: 33898784 Free PMC article.
-
Developments in deep learning based corrections of cone beam computed tomography to enable dose calculations for adaptive radiotherapy.Phys Imaging Radiat Oncol. 2020 Aug 12;15:77-79. doi: 10.1016/j.phro.2020.07.012. eCollection 2020 Jul. Phys Imaging Radiat Oncol. 2020. PMID: 33458330 Free PMC article. No abstract available.
-
Surveying the clinical practice of treatment adaptation and motion management in particle therapy.Phys Imaging Radiat Oncol. 2023 Jun 9;27:100457. doi: 10.1016/j.phro.2023.100457. eCollection 2023 Jul. Phys Imaging Radiat Oncol. 2023. PMID: 37361612 Free PMC article. No abstract available.
References
-
- Widesott L., Pierelli A., Fiorino C., Lomax A.J., Amichetti M., Cozzarini C. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis. Int J Radiat Oncol Biol Phys. 2011;80:1589–1600. doi: 10.1016/j.ijrobp.2010.10.005. - DOI - PubMed
-
- Rana S., Cheng C., Zheng Y., Risalvato D., Cersonsky N., Ramirez E. Proton Therapy vs. VMAT for prostate cancer: a treatment planning study. Int J Part Ther. 2014;1:22–33. doi: 10.14338/IJPT.13-00003.1. - DOI
LinkOut - more resources
Full Text Sources